Probiotics, touted for their health benefits, are raising FDA safety warnings and concerns about their use in infants, while regulatory challenges similarly impact fecal microbiota transplants (FMT). Consequently, medical professionals urge caution with probiotics and FMT in vulnerable groups, emphasizing potential risks over benefits.